Pattern of hypertensive kidney disease in a black Kenyan population

Cardiology

Volumn 120, Issue 3, 2012, Pages 125-129

  Ogeng'o, Julius A ^a   Gatonga, Patrick ^a   Olabu, Beda O ^a   Ongera, Dennis ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Black Kenyan population; Hypertension; Kidney disease

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; COMORBIDITY; CONGESTIVE HEART FAILURE; ETHNIC DIFFERENCE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERTENSIVE KIDNEY DISEASE; KENYA; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETINOPATHY; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CHILD; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION, RENAL; KENYA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SMOKING; YOUNG ADULT;

EID: 83455172800     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000334433     Document Type: Article

References (28)

1. Tahir K, Mujeeb M, Khalid S: Management of hypertensive nephropathy. J Biomed Sci Res 2010; 2: 295-301.
2. Naicker S: Challenges for nephrology practice in sub-Saharan Africa. Nephrol Dial Transplant 2010; 25: 649-650.
3. Veriara Y, du Toit E, Lawley CG, Milne FJ, Reinach SG: Hypertension as a cause of endstage renal failure in South Africa. J Hum Hypertens 1996: 4:379-383.
4. Barri YM: Hypertension and kidney disease. A deadly connection. Curr Hypertens Resp 2008: 10: 39-45. (Pubitemid 351255952)
5. Naicker S: End-stage renal disease in sub-Saharan Africa. Ethn Dis 2009,19:(S1)13-15.
6. Agodoa LY: Hypertensive kidney disease in African Americans. Nephrology 2001; 6: 25-31.
7. Arogundade FA, Barsoum RS: CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental and community support. AM J Kidney Dis 2008; 51: 515-523. (Pubitemid 351284498)
8. Jenson A, Omar AL, Omar AM, Rishad AS, Khoshnood K: Assessment of hypertension control in a district of Mombasa, Kenya. Glob Public Health 2011; 6: 293-306.
9. Tylicki L, Rutkowski B: Hypertensive nephropathy: pathogenesis, diagnosis and treatment. Pol Merkur Lekarski 2003; 14: 168-73. (Pubitemid 36288207)
10. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994; 23: 655.
11. Toto RB: Hypertensive nephrosclerosis in African Americans. Kidney Int 2003; 64: 2331-2341. (Pubitemid 37449578)
12. Lengani A, Laville M, Serme D, Fauvel JP, Quandaogo BJ, Zech P: Renal insufficiency in arterial hypertension in black Africa. Presse Med 1994; 23: 788-792.
13. Ulasi II, Ijoma CK: The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med 2010; 2010: 501957.
14. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, et al: Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28: 156-162.
15. Rahman M: African Americans with hypertensive kidney disease benefit from ACE inhibitor. Cleveland Clin J Med 2003; 70: 304-312. (Pubitemid 36527010)
16. Caetano ESRP, Zarz R, Saldanha LB, Praxedes JN: Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 2001; 38: 171-176. (Pubitemid 34224739)
17. Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P: Causes of chronic renal failure among Iranian hemodialysis patients. Saudi J Kid Dis Transpl 2009; 20: 501-504.
18. Gades MD, Stern JS, Van Goor H, Nguyen D, Johnson PR, Kaysen GA: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 1998; 53: 130-135. (Pubitemid 28066912)
19. Kevin C, Abott MD, George L, Bakris MD: Kidney failure and cardiovascular disease. Circulation 2003; 108:e114.
20. Sumaili EK, Krzesinski JM, Cohem EP, Nseka NM: Epidemology of chronic kidney disease in the Democratic Republic of Congo: Review of cross-sectional studies from Kinshasa, the capital. Nephrol Ther 2010; 6: 232-239.
21. Simon N, Frankin SS, Bleifer KH, Maxwell MH: Clinical characteristics of renovascular hypertension. JAMA 1972; 220: 1209-1218.
22. Sawicki PT, Kaiser S, Heinemann L, Frenzal H, Berger M: Prevalence of renal artery stenosis in diabetes mellitus-an autopsy study. J Intern Med 1991; 229: 489-492.
23. Zoccali C, Mallamaci F, Finocchiaro P: Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol 2002; 13:S179-S183. (Pubitemid 35216021)
24. Rutkowski P, Klassen A, Sebekora K, Bahnar U, Heidland A: Renal disease in obesity: the need for greater attention. J Renal Nutr 2006; 16: 216-223. (Pubitemid 43975009)
25. Sharkey D, Fainberg HP, Wilson V, Harvey E, Gardner DS, Symonds ME, Budge H: Impact of early onset obesity and hypertension on the unfolded protein response in renal tissues of juvenile sheep. Hypertension 2009; 53: 925-931.
26. Barsoum RS: Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997-999. (Pubitemid 43357803)
27. Johnson CA, Lavey AS, Coresh J, Levin J, Lau J, Eknoyan G: Clinical practice guidelines for chronic kidney disease in adults: Part 1. Definition, disease stages evaluation, treatment and risk factors. Am Fam Physician 2004; 70: 869-876. (Pubitemid 39201438)
28. Kashyap VS, Sepulveda RN, Bena JF, Nadly JV, Poggio ED, Greenberg RK, Yadar JS, Ouriel K: The management of renal artery atherosclerosis for renal salvage: Does stenting help? J Vasc Surg 2007; 45: 101-108. (Pubitemid 46038654)